Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation reports developments tied to its role as a diversified healthcare services company and major pharmaceutical distributor. Company news commonly covers fiscal results and guidance, dividend declarations, capital allocation, share repurchase activity, and updates across core distribution, oncology and multispecialty, biopharma services, pharmacy technology, and medical-surgical product categories.
McKesson updates also include portfolio actions and governance changes. Recent company materials document the completed divestiture of its Norwegian retail and distribution businesses, marking its exit from European operations, alongside recurring communications about earnings events, healthcare conferences, and leadership succession matters.
McKesson (NYSE: MCK) released its fiscal 2026 fourth-quarter results and is hosting a live earnings webcast and conference call today, May 7 at 4:30 PM ET.
According to McKesson, the audio webcast will be available live and archived on the company’s Investor Relations site, along with the earnings release, financial tables, and slide presentation.
McKesson (NYSE:MCK) declared a regular quarterly dividend of $0.82 per share. The Board approved the dividend, which is payable on July 1, 2026 to shareholders of record as of June 1, 2026.
McKesson (NYSE: MCK) agreed April 20, 2026 to sell an approximate 13% minority interest in its Medical-Surgical Solutions (MMS) business to funds managed by Apollo for $1.25 billion in convertible preferred equity, valuing MMS at about $13 billion enterprise value.
McKesson will retain majority ownership and operating control, continue to consolidate MMS results, and said the deal supports its planned separation and IPO; the transaction remains subject to regulatory approvals and customary closing conditions.
McKesson (NYSE: MCK) will release fourth quarter fiscal 2026 results after market close on Thursday, May 7, 2026, followed by a live investor webcast at 4:30 PM ET hosted by CEO Brian Tyler and CFO Britt Vitalone.
Mr. Vitalone will participate in the Leerink Partners and Barclays Global Healthcare Conferences on March 11, 2026 and the BofA Securities 2026 Healthcare Conference in May 2026. McKesson reaffirmed its fiscal 2026 full year outlook as previously issued on February 4, 2026. Webcasts will be available on McKesson’s investor website.
McKesson (NYSE: MCK) announced that Britt Vitalone will retire as Executive Vice President and Chief Financial Officer after a 20-year career, including more than eight years as CFO. Kenny Cheung will join as Executive Vice President and CFO, effective May 29, 2026.
Vitalone will remain with McKesson as a strategic advisor to support the transition and the planned separation of McKesson's Medical Surgical Solutions. The company reported a strong third quarter with record revenue and adjusted operating profit, driven by oncology, multispecialty and biopharma services and core distribution strength.
McKesson (NYSE: MCK) released its fiscal 2026 third quarter results and is hosting an earnings webcast today, Wednesday, February 4 at 4:30 PM ET. Investors can access the live audio webcast and archived materials, including the earnings release, financial tables, and slide presentation, on McKesson's Investor Relations website.
Additional investor events and presentations are listed at the company’s investor site.
McKesson (NYSE: MCK) has completed the sale of its retail and distribution businesses in Norway to NorgesGruppen, closing the transaction on January 30, 2026. This divestiture completes McKesson’s exit from its European operations and frees strategy and capital to prioritize growth in Oncology, Multispecialty and Biopharma Services.
Additional divestiture details will be discussed on the company’s Fiscal Third Quarter Earnings call on February 4, 2026 and posted on the investor relations website.
McKesson (NYSE: MCK) declared a quarterly cash dividend of $0.82 per share. The Board set the record date as March 2, 2026, and the payment date as April 1, 2026. This is a regular dividend payable to common shareholders.
McKesson (NYSE: MCK) will release third quarter fiscal 2026 results after market close on Wednesday, February 4, 2026. The company will host an investor earnings conference call and live webcast at 4:30 PM Eastern Time to review results. The live and archived audio webcast will be available on McKesson's Investor Relations website.
McKesson (NYSE: MCK) released its fiscal 2026 second quarter results and will host a live earnings conference call on Wednesday, November 5, 2025 at 4:30 PM ET.
Investors can access the live audio webcast, archived replay, earnings press release, financial tables, and slide presentation on McKesson's Investor Relations website at investor.mckesson.com.
Additional investor events and presentation schedules are listed at investor.mckesson.com/events-and-presentations.